About Elongation factor 1-gamma
Elongation factor 1-gamma (EEF1G) is a protein
from Homo sapiens identified by UniProt accession
P26641, 437 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Elongation factor 1-gamma |
| UniProt accession | P26641 |
| Gene | EEF1G |
| Organism | Homo sapiens |
| Length | 437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.52
- cancer · score 0.47
- BMI-adjusted waist-hip ratio · score 0.17
- physical activity measurement · score 0.15
- high density lipoprotein cholesterol measurement · score 0.12
- endometrial cancer · score 0.11
- forced expiratory volume · score 0.10
- diet measurement · score 0.09
- waist-hip ratio · score 0.09
- BMI-adjusted waist circumference · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P26641-F1 | alphafold | PREDICTED | 85.74 | — |
Amino-acid sequence (437 residues)
MAAGTLYTYP ENWRAFKALI AAQYSGAQVR VLSAPPHFHF GQTNRTPEFL RKFPAGKVPA FEGDDGFCVF ESNAIAYYVS NEELRGSTPE AAAQVVQWVS FADSDIVPPA STWVFPTLGI MHHNKQATEN AKEEVRRILG LLDAYLKTRT FLVGERVTLA DITVVCTLLW LYKQVLEPSF RQAFPNTNRW FLTCINQPQF RAVLGEVKLC EKMAQFDAKK FAETQPKKDT PRKEKGSREE KQKPQAERKE EKKAAAPAPE EEMDECEQAL AAEPKAKDPF AHLPKSTFVL DEFKRKYSNE DTLSVALPYF WEHFDKDGWS LWYSEYRFPE ELTQTFMSCN LITGMFQRLD KLRKNAFASV ILFGTNNSSS ISGVWVFRGQ ELAFPLSPDW QVDYESYTWR KLDPGSEETQ TLVREYFSWE GAFQHVGKAF NQGKIFK
Explore Elongation factor 1-gamma with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets